Supernus Pharmaceuticals SUPN Professional service fees
Professional service fees at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's professional service fees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Supernus Pharmaceuticals's professional service fees?
- Supernus Pharmaceuticals (SUPN) reported professional service fees of $16.12M in Q1 2026.
- How has Supernus Pharmaceuticals's professional service fees changed year-over-year?
- Supernus Pharmaceuticals's professional service fees increased by 8.7% year-over-year, from $14.83M to $16.12M.
- What is the long-term trend for Supernus Pharmaceuticals's professional service fees?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's professional service fees has grown at a 16.6% compound annual growth rate (CAGR), from $7.73M to $16.67M.